Content about Pharmacist Society

June 18, 2013
Avella joins limited distribution network for orally administered cancer drug

Avella Specialty Pharmacy will be included in the limited distribution network for a cancer drug made by Genentech, Avella said Tuesday.

June 18, 2013
FDA has collected more than $255 million in generic drug user fees, nearing $299 million goal

The Food and Drug Administration's Center for Drug Evaluation and Research has collected 84% of the fees it intends to collect this year under a law passed last year to collect user fees from generic drug members, according to a memo sent out to CDER staff Tuesday.

June 18, 2013
Healthcare spending growth to drop next year, PwC report finds

Spending on health care will slow down in 2014 despite a flood of new patients who will have insurance, according to a new study.

June 18, 2013
Mylan hires NFL player, TV personality to promote EpiPen

A division of Mylan is hiring NFL player Adrian Peterson and family expert Jo Frost to promote an emergency treatment for severe allergic reactions.

June 18, 2013
Royalty Pharma drops bid for Elan Corp.

Royalty Pharma will not buy Irish drug maker Elan Corp., the company said Tuesday.

June 18, 2013
Teva to acquire MicroDose for up to $165 million

Teva Pharmaceutical Industries will spend up to $165 million to buy a company developing a drug to prevent viral respiratory infections.

June 18, 2013
With nuanced ruling on ‘pay for delay,’ Supreme Court hands generics partial resolution

Half a loaf, the saying goes, is better than none. For the generic drug industry, that means that the Supreme Court handed it a partial victory Monday by ruling that “pay for delay” patent settlements between brand name and generic drug companies aren’t necessarily illegal and should be considered on a case-by-case, “rule of reason” approach by the Federal Trade Commission, which staunchly opposes the practice.

June 17, 2013
BioScrip to acquire CarePoint Partners for $223 million

BioScrip will acquire a Cincinnati-based home infusion company for $223 million, BioScrip said Monday.

June 17, 2013
J&J to buy Aragon Pharmaceuticals for up to $1 billion

Drug maker Johnson & Johnson plans to spend up to $1 billion to acquire a privately owned company developing a drug for prostate cancer.

June 17, 2013
Perrigo to acquire Fera's ophthalmic portfolio for up to $129 million

Perrigo Co. will pay up to $129 million to buy Fera Pharmaceuticals' portfolio of ophthalmic products, Perrigo said.

June 17, 2013
Supreme Court issues 'pay-for-delay' ruling

Patent settlements between brand and generic drug makers commonly referred to as "pay-for-delay" settlements are not necessarily against the law, the Supreme Court ruled Monday.

June 17, 2013
Walgreens donation helps provide 35,000 doses of flu vaccine to at-risk populations in Laos and Nicaragua

Walgreens today announced a donation to the Pan American Health Organization to help make 35,000 doses of flu vaccine available to at-risk populations in Laos and Nicaragua, building upon a successful public-private initiative to help create greater access to seasonal flu vaccine in developing countries.

June 14, 2013
New York-based company may acquire Elan Corp.

Irish drug maker Elan Corp. said Friday it was looking to sell itself off to a New York-based company that invests in drug royalties after rejecting a previous offer.

June 13, 2013
Actavis partners with Medicines360 to sell low-cost IUDs in public clinics

Drug maker Actavis is working with nonprofit pharmaceutical company Medicines360 to make low-cost intrauterine devices available to women, the two said.

June 13, 2013
Bartell Drugs seeks participant for bike rider in cancer-research benefit

Regional drug store chain Bartell Drugs is looking for a volunteer to represent it in a bike ride to raise money for a local cancer-research center.

June 13, 2013
Emdeon buys Goold Health Systems

Emdeon has bought a company that provides pharmacy benefit and related services to state Medicaid agencies, Emdeon said.

June 13, 2013
FDA approves Amgen's Xgeva for giant cell tumor of the bone

The Food and Drug Administration has approved a drug made by Amgen for treating a rare and usually noncancerous bone tumor, the agency said Thursday.

June 13, 2013
Home health care shows strongest job growth in healthcare sector, May data show

Most of the growth in jobs in the healthcare sector comes from home health care, according to data released this month by the Bureau of Labor Statistics.

June 13, 2013
Ohio event to demonstrate, promote telehealth in state

A state legislator in Ohio is sponsoring an open-house event to demonstrate advances in telemedicine.

June 12, 2013
Avella releases guide to specialty pharmacy for payers

Avella Specialty Pharmacy has released a new white paper for payers selecting new specialty pharmacy partners, the company said Wednesday.

June 12, 2013
Meijer opens two new Ind. stores

Meijer will open two new stores in northern Indiana, the mass merchandise retailer said.

June 12, 2013
Miss. attorney general calls on Google to remove rogue pharmacy ads

Google has removed advertisements for websites that sell drugs without prescriptions, following a series of warning letters from a state attorney general, according to published reports.

June 12, 2013
PhRMA: 215 drugs under development for cardiovascular disease

More than 200 drugs are under development for cardiovascular disease, according to a drug industry trade group.

June 12, 2013
QS/1 receives controlled substances e-prescribing certification

Pharmacy automation provider QS/1 has received certification for controlled substances prescribed electronically, the company said.

June 12, 2013
Rite Aid sponsors sixth annual healthy-skin tour in July

Rite Aid will offer free informational resources in its stores and online on summer skin care, as well as sponsoring a cross-country tour offering full-body skin cancer screenings, the drug store chain said Wednesday.

© 2013 Drug Store News. All Rights Reserved.